UnitedHealth Group Incorporated $UNH Shares Sold by Great Diamond Partners LLC

by · The Cerbat Gem

Great Diamond Partners LLC cut its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 80.9% during the 2nd quarter, according to its most recent filing with the SEC. The institutional investor owned 672 shares of the healthcare conglomerate’s stock after selling 2,848 shares during the period. Great Diamond Partners LLC’s holdings in UnitedHealth Group were worth $210,000 at the end of the most recent reporting period.

Other institutional investors have also made changes to their positions in the company. Bayforest Capital Ltd increased its position in shares of UnitedHealth Group by 685.7% during the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after acquiring an additional 48 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd raised its stake in shares of UnitedHealth Group by 416.7% in the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock valued at $32,000 after purchasing an additional 50 shares in the last quarter. LFA Lugano Financial Advisors SA acquired a new position in UnitedHealth Group in the second quarter worth about $25,000. Islay Capital Management LLC acquired a new stake in UnitedHealth Group during the second quarter valued at approximately $31,000. Finally, Nova Wealth Management Inc. grew its position in shares of UnitedHealth Group by 339.1% in the 1st quarter. Nova Wealth Management Inc. now owns 101 shares of the healthcare conglomerate’s stock worth $53,000 after acquiring an additional 78 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Stock Down 1.7%

Shares of UNH stock opened at $333.81 on Friday. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.82 and a current ratio of 0.82. The stock has a market cap of $302.38 billion, a PE ratio of 17.42, a price-to-earnings-growth ratio of 2.22 and a beta of 0.43. The business’s fifty day moving average is $342.06 and its 200-day moving average is $315.83. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $608.99.

UnitedHealth Group (NYSE:UNH – Get Free Report) last issued its quarterly earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share for the quarter, beating analysts’ consensus estimates of $2.87 by $0.05. The company had revenue of $113.16 billion during the quarter, compared to the consensus estimate of $113.19 billion. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. UnitedHealth Group’s revenue was up 12.2% on a year-over-year basis. During the same period in the prior year, the company earned $7.15 EPS. Equities analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 16th. Stockholders of record on Monday, December 8th will be issued a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a dividend yield of 2.6%. The ex-dividend date of this dividend is Monday, December 8th. UnitedHealth Group’s dividend payout ratio is currently 46.14%.

Wall Street Analysts Forecast Growth

UNH has been the topic of a number of recent research reports. Zacks Research upgraded shares of UnitedHealth Group from a “strong sell” rating to a “hold” rating in a research report on Monday, October 6th. Leerink Partners set a $410.00 target price on UnitedHealth Group and gave the company an “outperform” rating in a research note on Wednesday, October 29th. Royal Bank Of Canada increased their price target on UnitedHealth Group from $286.00 to $408.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 29th. Morgan Stanley upped their price objective on UnitedHealth Group from $325.00 to $395.00 and gave the stock an “overweight” rating in a research note on Friday, September 12th. Finally, Deutsche Bank Aktiengesellschaft cut UnitedHealth Group from a “buy” rating to a “hold” rating and set a $333.00 target price on the stock. in a research note on Wednesday, October 29th. Seventeen research analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $385.54.

Check Out Our Latest Stock Analysis on UNH

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Stories